Global Cell Banking Outsourcing Market Size, Status and Forecast 2020-2026

A cell bank is a facility that stores cells of specific genome for the purpose of future use in a product or medicinal needs. They often contain expansive amounts of base cell material that can be utilized for various projects. Cell banks can be used to generate detailed characterizations of cell lines and can also help mitigate cross-contamination of a cell line. Utilizing cell banks also reduces the cost of cell culture processes, providing a cost-efficient alternative to keeping cells in culture constantly. Cell banks are commonly used within fields including stem cell research and pharmaceuticals, with cryopreservation being the traditional method of keeping cellular material intact. Cell banks also effectively reduce the frequency of a cell sample diversifying from natural cell divisions over time. Cells mainly used in the regenerative medicine production. Increasing demand of stem cell therapies and number of cell banks expected to boost the global market.
Cell banking is a process of replicating and storing cells for the purpose of future use. Storage of these cell samples can be utilized for research purposes and for surgical reconstruction of damaged body structures. Cells are frozen in cryovials at -196 degrees Celsius along with cryoprotection agents such as 10% solution of DMSO. Cell banking is most commonly used in stem cell research and therapy.
Market Analysis and Insights: Global Cell Banking Outsourcing Market
In 2019, the global Cell Banking Outsourcing market size was US$ 5860.8 million and it is expected to reach US$ 17900 million by the end of 2026, with a CAGR of 17.1% during 2021-2026.
Global Cell Banking Outsourcing Scope and Market Size
Cell Banking Outsourcing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cell Banking Outsourcing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Cell Banking Outsourcing market is segmented into Stem Cell Banking, Non-stem Cell Banking, etc.
Segment by Application, the Cell Banking Outsourcing market is segmented into Cell Bank Storage, Bank Characterization and Testing, Cell Bank Preparation, etc.
Regional and Country-level Analysis
The Cell Banking Outsourcing market is analysed and market size information is provided by regions (countries).
The key regions covered in the Cell Banking Outsourcing market report are North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.

Competitive Landscape

and Cell Banking Outsourcing Market Share Analysis
Cell Banking Outsourcing market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Cell Banking Outsourcing business, the date to enter into the Cell Banking Outsourcing market, Cell Banking Outsourcing product introduction, recent developments, etc.
The major vendors include SGS Life Sciences, Lonza, CCBC, Vcanbio, AMAG Pharmaceuticals, ViaCord, Thermo Fisher, Wuxi Apptec, CordLife, Esperite, Reliance Life Sciences, Lifecell, Cryo-Cell, Toxikon, Goodwin Biotechnology, Texcell, Cryo Stemcell, etc.

This report focuses on the global Cell Banking Outsourcing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cell Banking Outsourcing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

SGS Life Sciences
Lonza
CCBC
Vcanbio
AMAG Pharmaceuticals
ViaCord
Thermo Fisher
Wuxi Apptec
CordLife
Esperite
Reliance Life Sciences
Lifecell
Cryo-Cell
Toxikon
Goodwin Biotechnology
Texcell
Cryo Stemcell

Market segment by Type, the product can be split into

Stem Cell Banking
Non-stem Cell Banking

Market segment by Application, split into

Cell Bank Storage
Bank Characterization and Testing
Cell Bank Preparation

Market segment by Regions/Countries, this report covers

North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:

To analyze global Cell Banking Outsourcing status, future forecast, growth opportunity, key market and key players.
To present the Cell Banking Outsourcing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Cell Banking Outsourcing are as follows:
History Year: 2015-2019

Base Year:

2019

Estimated Year:

2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Frequently Asked Questions